Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.

Erik SchönfelderAlma OsmanovicLars Hendrik MüschenSusanne PetriOlivia Schreiber-Katz

Published in: Orphanet journal of rare diseases (2020)

It is essential to understand the socioeconomic burden of a disease. These data can be used to improve patient care standards and quality of life while also serving as a basis for cost-benefit analyses during the approval process of new treatments.

Keyphrases

electronic health record
amyotrophic lateral sclerosis
big data
risk factors
machine learning
deep learning
artificial intelligence